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ABSTRACT 
Introduction: Regular blood transfusion for β-thalassemia patients is a life-saving therapy, hence, 
it results in iron overload lead to immune dysregulation triggered by chronic activation of immune 
system. This fundamental notion contributes to their morbidity and mortality. Monocyte plays a 
critical role in regulating and bridging innate to adaptive immunity. Our pilot study analyzed the 
presence of activation markers, CD14 and CD69, on monocyte of major β-thalassemia patients 
associated with their iron status. Method: Fifty pediatric β-thalassemia patients routinely visited 
thalassemia clinic for clinical examination and blood transfusion were involved in this cross-sectional 
study. Flow cytometry applying antibody of CD14, HLA-DR, CD69 was used to dissect CD14+CD69+ 
monocytes from lysed-erythrocyte heparinized whole blood and defined as cell percentage also median 
fluorescent intensity (MFI) of CD69 of CD14+CD69+ monocytes. Iron status was indicated by ferritin 
and serum iron level. A correlation study was done. Results : We found 87.4% (76.1 – 91.4) 
CD14+CD69+ of dissected monocytes from iron overloaded pediatric β-thalassemia patients (Ferritin 
level: 3118 µg/L, 1675 – 9718). Positive correlation was found between percentage of CD14+CD69+ 
monocytes and ferritin level (r = 0.3, P = 0.04).  Conclusion: Considering the function of CD14 and 
CD69 on monocyte and the iron accumulation, our result may implicate that pediatric major β-
thalassemia patients have a tendency towards chronic inflammation. Future direction for research of 
our study aimed at discovering collateral activation of immune cells via monocyte to explain organ 
damage caused by iron overload is imperative. 
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INTRODUCTION 
Beta (β)-thalassemia is a blood genetic disease 
caused by the alteration of beta chains of 
hemoglobin protein synthesis distributed 
worldwide according to thalassemia belt where 
Indonesia was included (1). The major type of this 
disease depended on regular blood transfusion to 
overcome the anemia caused by accelerated 
hemolysis and ineffective erythropoiesis (1). 
Nowadays, major β-thalassemia patients have a 
convenient access to the definite therapy, 
therefore increased their life expectancy. However 
this fact resulted into an inevitable iron overload 
condition which is related to persistent 
inflammation and increased risk for infection (2, 3). 
Monocyte is a professional innate sentinel cell 
that participates in various inflammatory 
conditions through activation and recruitment in 
response to many cytokines. In addition, this cell 
bridges innate and adaptive immunities that also 
play a major role in iron regulation (4). These 
integrated activities of monocytes can be studied 
by identifying and measuring their membrane 
protein. Previous study has showed that monocyte 
of thalassemia patients underwent hyperplasia 
and is hyperactive however demonstrate the low 
phagocytic activity in inflammation insult (3), 
however how monocyte was activated and 
therefore started the inflammation cascade in 
thalassemia patients need to be further 
elaborated. 
CD69 is a C-type transmembrane lectin which 
is constitutively expressed in monocytes. Increase 
of which has been dubbed as an activation 
indicator of this cell (5-7). All these studies lead us 
to think that there is an immune alteration 
caused by the constant state of iron overload. We 
hypothesize that monocytes are affected by the 
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constant state of iron overload and activating the 
monocyte via this protein. 
 
METHODS 
Study Design, participants, and procedure  
A study implementing cross sectional and 
analytic design involving 50 pediatric major β-
thalassemia patients that routinely visited the 
Thalassemia Clinic of Hasan Sadikin General 
Hospital, Bandung, West Java was done. 
Inclusion criteria were β-thalassemia sufferers 
aged under 15 confirmed by genetic examination 
and had been transfused at least 2 years or more. 
Exclusion criteria were diabetes, autoimmune, 
cancer, tuberculosis, chronic infections such as 
HBV and HIV, and immunomodulatory treated 
patients. 
 
Ethics 
Ethics of this study was made in accordance to 
with Faculty of Medicine Universitas Padjadjaran 
and Hasan Sadikin General Hospital. The study 
was approved under the approval number of 
74/UN6.C1.3.2/KEPK/PN/2016 and 
LB.02.01/C02/15691/XI/2016 for Faculty of 
Medicine and ethics committee of Dr. Hasan 
Sadikin Hospital respectively. 
 
Laboratory Procedures 
Characterization of CD69 monocytes 
Blood was drawn from 50 patients through 
venipuncture and placed in vacutainer with 
lithium and sodium heparin. The blood was stored 
for 1 hour in room temperature before being 
analyzed. The tube that contains 200µL of 
heparinized blood was treated with 2000µL of 
PBA 0.5% and then vortexed/centrifuged for 5 
minutes without break at 1500 rpm. The 
suspension is vortexed in FACS buffer with the 
antibodies, incubated for 20 minutes at 2-8oC, 
covered by aluminum foil, given ten –time diluted 
red cell lysing buffer, incubated again for 12 
minutes, and lastly washed with 2000µL PBA 
0.5% and suspended with 200µL PBA 0.5%.  
After preparations were done, the samples were 
put into flow cytometer. The antibodies used were 
HLA-DR, CD14, and CD69 antibodies (All from 
BioLegend, San Diego, CA, USA). Cells were read 
according to their phenotypic marker by BD Cell 
Quest Pro Software (Biosciences, San Jose, CA, 
USA) for 500,000 events, then the FCM output 
files were analyzed using FlowJo 10 (Tree star, 
USA). The monocytes were distinguished from 
granulocytes and lymphocytes with forward and 
side scatter, HLA-DR, and CD16 subsequently. 
The gated result was analyzed with CD14/CD69. 
The percentage that positively express CD69 and 
the mean fluorescent intensity (MFI) was 
recorded. 
 
Hematology assessment: Complete Blood Count 
(CBC) 
Vacutainer containing potassium EDTA (Becton 
Dickinson, Franklin Lakes, New Jersey, USA) 
was used for CBC. Automatic hematology 
analyzer (Sysmex Corp., Japan) was employed to 
measure hemoglobin (Hb), leukocyte, monocyte, 
mean corpuscular volume (MCV), mean 
corpuscular hemoglobin (MCH), and mean 
corpuscular hemoglobin concentration (MCHC). 
 
Iron status measurement 
Sera were extracted were analyzed for iron status. 
Serum iron and ferritin kit, The Elecsys ferritin 
immunoassay kit (Roche, Switzerland), was used 
to get ferritin concentration. All data was 
analyzed with a correlation study. Serum iron 
assay kit (Merck, Singapore) was used to measure 
serum iron.  
 
Statistical analysis 
Data with non-normally distribution are 
presented as median with interquartile range 
(IQR), while normally distributed data as mean 
with standard deviation (SD). Correlation 
between parameters was tested using Spearman 
correlation coefficient for non-normally 
distributed data, and Pearson correlation 
coefficient for normally distributed data. All 
analyses were performed with GraphPad PRISM 
version 7.0 (Graphpad Software, Inc., La Jolla, 
CA, USA). P < 0.05 is considered statistically 
significant. 
 
RESULTS 
Identification of CD69 monocytes 
The CD14+CD69+ monocyte population result 
was depicted in figure 1. The selection of monocyte 
began by distinguishing the monocyte population 
according to size and granularity. Positive gating 
of the selected population employing HLA-DR and 
CD14 on monocyte membrane expression was 
used to identify true monocytes. Further, HLA-
DR+CD14+ monocytes were selected. The final 
result, CD69+ monocytes of true monocytes were 
counted also the MFI of CD69 expression was 
measured as showed in table 1. 
 
Hematologic characteristic 
Hematologic data acquired which depicted in 
Table 2 showed an excess of serum iron and 
ferritin content in these patients. 
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Correlation result 
Results show ferritin is a significant positively 
correlated with CD14+CD69+ monocytes of total 
monocytes and CD14+HLA-DR+ monocytes. These 
p values are significant (p<0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Identification of blood monocyte subset applying multicolor flow cytometry. Gating strategy for 
monocyte subsets identification presenting successive inclusion of monocytes population. (A.) Identification 
of monocyte subpopulation in blood. (B.) Selection for “true” monocytes by gating on CD14 positive and HLA-
DR positive population. (C.) Remaining population was further discriminated on a CD14 vs. CD69 
scatterplot to give CD14+CD69+ monocytes. 
 
Table 1. Population of Monocytes 
 Patients value 
CD69+CD14+ monocyte (%) 
(Mean) 
39.02 
Median MFI of CD69 of 
CD14+CD69+ monocyte 
80.2 
 
Table 2. Correlation of monocyte characteristics in pediatric β-thalassemia patients 
Parameter Value 
Serum iron CD14+/CD69+ of Total monocytes r0.121 
p0.404 
CD14+/CD69+ of CD14+/HLA-DR+ r0.044 
p0.759 
Mean MFI for CD69+ of CD14+ /CD69+ r-0.004 
p0.978 
Median MFI for CD14+/CD69+ r-0.021 
p0.887 
Ferritin CD14+/CD69+ of Total monocytes r0.278 
p0.050 
CD14+/CD69+ of CD14+/HLA-DR+ r0.291 
p0.040 
Mean MFI for CD69+ of CD14+ /CD69+ r0.012 
p0.934 
Median MFI for CD14+/CD69+ r0.015 
p0.916 
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Table 3. Clinical Characteristics 
 Patients’ value Normal value 
Gender   
• Male, n (%) 
Female, n (%) 
25 (50) 
25 (50) 
Not Defined 
Not Defined 
Mean age (SD), year 
Hematological assessment 
• Mean Hb (SD), g/dL 
• Median leucocyte (IQR), /mm3 
• Median monocyte count (IQR), % 
• Median MCV (IQR), fl 
• Mean MCH (SD), pg/cell 
• Mean MCHC (SD), g/dL 
Iron status 
• Median ferritin (IQR), µg/L 
Mean serum iron (SD), µg/dL 
8 (3.0) 
 
6.5 (1.2)          
6000 (4000-8100) 
6 (5-7) 
75.6 (71.2-78.6) 
25.5 (2.7) 
34.3 (1.6) 
 
3118 (1675-5009) 
163.5 (60.4) 
Not Defined 
> 29 
 
10.9-14.9 
4500-14500 
 
79-98 
25-33 
32-36 
 
< 1000 
35-150 
DISCUSSION 
Monocyte has pivotal function in bridging the 
interplay between innate and adaptive immune 
cells in the progression of inflammation. 
Activated blood circulating monocytes are 
recognized by the expression HLA-DR protein on 
their cell membrane, while the pro-inflammatory 
ones are when they are expressing CD14 and 
CD69 (6, 8-10). These facts suggested that in major 
β-thalassemia patients burdened with iron 
overload complication the existence of 
CD14+CD69+ monocyte play important role in the 
pathogenesis of persistent inflammation 
happened in major β-thalassemia. 
The results acquired shows that there is a 
moderate positive correlation between ferritin 
level and the percentage of CD14+CD69+ 
monocyte population. Monocyte activation can be 
shown via the CD69 protein. This protein is 
encoded in chromosome 12p13. The cross-linking 
of this protein increases monocyte in producing 
prostaglandin, leukotriene B4, nitric oxide, and 
extracellular calcium influx (5-7, 11). These 
functions implicate CD69 as a pro-inflammatory 
protein on monocyte. CD69 has shown increase in 
persistent inflammatory conditions, such as 
sarcoidosis and HIV. It is implicated in activation 
of monocytes, in which it is also tied to an 
induction of TNF-α release by macrophages (12). 
The activation process or status in monocytes has 
also been related to more release of cytokines but 
less on phagocytic function. Studies showed a 
downgrading effect of monocyte activation 
making phagosomes less efficient (13, 14). 
Iron may be significant to monocytes because 
the life cycle of erythrocytes ends in phagocytosis. 
Release of iron and storage of iron in the form of 
ferritin is exactly why monocytes can be affected. 
To manage iron content, cells such as monocytes 
express proteins such as DMT (Nramp2) to 
internalize iron. Free iron has to be controlled not 
just because of its dangers but also because of its 
benefits to microbes. In conditions of iron 
overload, free iron that is very toxic to the cells 
and tissues is formed and may continue to rise 
and catalyze the production of radical OH- 
substances from peroxide molecules, known as the 
Fenton reaction. At the final phase, this condition 
endangered cell function by damaging their 
biomolecules and inflammation. This study shows 
excess of iron indicated by higher ferritin and 
serum iron level.  
As iron levels rise in the blood, hepcidin need to 
create a waste disposal environment rather than 
keeping the balance. Thus, hepcidin functions to 
keep the internalizer, which is DMT, but turns off 
the externalizer, which is ferroportin. These 
findings in iron overloaded patients is why 
monocytes can become a reservoir for iron and 
hence became intoxicated by it. To prevent that, 
iron has to be contained in its more stable form 
which is incorporated into ferritin. However, this 
mechanism most likely to be imbalanced. May be 
this is why there is a correlation between ferritin 
content and the CD69 protein. But, since CD69 is 
indicated by many as an “activation” marker, and 
a part of the pro-inflammatory mechanism, how is 
it related to iron?  
Our humble suspicion is that the main link 
between iron and activation in monocytes might 
be NFκB. A study in kupffer cells in the liver 
showed that iron in its ferrous form blocks IkBα, 
increased the number of p65 and p65/p50 binding 
to DNA, and it is a direct agonist to the IKK. 
These evidence may be the tying knot between 
iron and the activation of monocytes because it 
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shows a preference to the activation of NFκB 
canonical pathway, and CD69 may be a part of 
this pathway. 
As many substances triggered by the canonical 
pathway is activated, an inflammatory state is 
created. The canonical pathway may affect the 
behavior of the monocytes because of the constant 
activation. High iron content, and hence the high 
ferritin content may just be the reason why the 
canonical pathway is more active and hindering 
the balance because the alternative pathway is 
constantly off. The imbalance in immune function 
may just be the reason why there is an increased 
susceptibility to infections and hence increased 
mortality rate in patients with iron overload. 
 
CONCLUSION 
Considering the function of CD14 and CD69 on 
monocyte and the iron accumulation, our result 
may implicate that pediatric major β-thalassemia 
patients have a tendency towards chronic 
inflammation. Thus CD14+CD69+ monocytes are 
implicated as marker of chronic inflammation in 
patients suffering from iron overload and early 
identification by this study makes it even more 
pronounced. Many more studies are needed to 
increase our understanding of the mechanisms 
with which iron overload causes immune 
dysregulation. Future direction for research of our 
study aimed at discovering collateral activation of 
immune cells via monocyte to explain organ 
damage caused by iron overload is imperative. 
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